Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  211.21
-3.99 (-1.86%)
AAPL  251.23
-3.00 (-1.18%)
AMD  202.26
+5.95 (3.03%)
BAC  47.08
-0.20 (-0.42%)
GOOG  308.08
-1.33 (-0.43%)
META  620.01
-2.65 (-0.43%)
MSFT  394.12
-5.29 (-1.32%)
NVDA  182.97
+1.04 (0.57%)
ORCL  154.66
-0.03 (-0.02%)
TSLA  398.17
-1.10 (-0.28%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.